Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Pyoderma Gangrenosum
NCT00730717Phase 2Withdrawn
- Sponsor
- Wright State University
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in pyoderma gangrenosum (PG), sponsored by Wright State University. Planned start May 2009; status: withdrawn.
02
Drugs
03
Conditions
pyoderma gangrenosum (PG)
Beyond the preview
Go deeper on NCT00730717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730717.